Central Illustration.

Echocardiographic Evaluation During and After Cancer Treatment

Proposed algorithm on the use of left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) to guide clinical decision making pertaining to asymptomatic patients at risk for left ventricular (LV) dysfunction. Patients with cardiac symptoms warrant additional evaluation. ∗Marker of increased risk of cancer therapeutic related cardiac dysfunction. Optimize existing cardiovascular risk factors, consider cardioprotective medications. ∗∗Initiate cardioprotective medications as per American College of Cardiology/American Heath Association guideline for the management of Stage B heart failure.